Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas
- 285 Downloads
Object We analyzed MMP-9 expression using mRNA and protein level determinations and explored the possibility that Matrix metalloproteinase-9 (MMP-9) is a potential biological marker of pituitary adenoma invasiveness and whether MMP-9 could be used to discriminate the extent of invasiveness among different hormonal subtypes, tumor sizes, growth characteristics, and primary versus recurrent tumors. Materials and methods 73 pituitary tumor specimens were snap frozen in liquid nitrogen immediately after surgical resection. RNA and protein were extracted. MMP-9 mRNA transcripts were analyzed by quantitative RT-PCR. MMP-9 protein activity was analyzed by gelatin zymography and validated by western blot analysis. Immunohistochemistry was performed to identify the presence and localization of MMP-9 in pituitary adenomas. Statistical differences between results were determined using Student’s t-test or one way ANOVA. Results Comparing different hormonal subtypes of noninvasive and invasive pituitary tumors, MMP-9 mRNA expression was significantly increased in the majority of invasive adenomas. Considering the protein levels, our data also showed a significant increase in MMP-9 activity in the majority of invasive adenomas and these differences were confirmed by western blot analysis and immunohistochemistry. In addition, consistent differences in MMP-9 expression levels were found according to tumor subtype, tumor size, tumor extension and primary versus redo-surgery. Conclusions MMP-9 expression can consistently distinguish invasive pituitary tumors from noninvasive pituitary tumors and would reflect the extent of invasiveness in pituitary tumors according to tumor subtype, size, tumor extension, primary and redo surgery, even at early stages of invasiveness. MMP-9 may be considered a potential biomarker to determine and predict the invasive nature of pituitary tumors.
KeywordsMatrix metalloproteinase Pituitary tumor Invasion Noninvasion Biological marker
We are grateful to Dr. Yunde Bao (Department of Microbiology, University of Virginia Health System) for excellent technical support.
- 5.Trouillas J, Daniel L, Guigard MP, Tong S, Gouvernet J, Jouanneau E, Jan M, Perrin G, Fischer G, Tabarin A, Rougon G, Figarella-Branger D (2003) Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. J Neurosurg 98:1084–1093PubMedGoogle Scholar
- 18.Zucker S, Lysik RM, Zarrabi MH, Moll U (1993) M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. CancerRes 53:140–146Google Scholar
- 22.Zhao YG, Cao XM, Xiao AZ, Zhu C (1999) Expression of MMP-2, -9,TIMP-1, -2, -3 mRNA in rat uterus during estrous cycle. Dev Reprod Biol 8:1–10Google Scholar
- 26.Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GKK, Lopes MBS, Laws ER (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170(1):356–365PubMedCrossRefGoogle Scholar
- 36.Scheithauer BW (1982) Surgical pathology of the pituitary and sellar region. In: Laws ER Jr, Randall RV, Kern EB et al (eds) Management of pituitary adenomas and related lesions with emphasis on transsphenoidal microsurgery. Appleton-Century-Crofts, New York, pp 129–218Google Scholar
- 38.Kovacs K, Horvath E (1986) Adenomas with ACTH production. In Tumors of the pituitary gland. Armed Forces Institute of Pathology, Washington, pp 134–164Google Scholar
- 42.Knappe UJ, Ludecke DK (1996) Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing’s disease. Acta Neurochir (Wien) 65(Suppl):31–34Google Scholar
- 45.Scotti G, Yu CY, Dillon WP, Norman D, Colombo N, Newton TH, De Groot J, Wilson CB (1988) MR imaging of cavernous sinus involvement by pituitary adenomas. AJNR 9:657–664Google Scholar